1-3 of 3
Rebecca E. Schweppe
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fibronectin Contributes to a BRAF Inhibitor–driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2

Available to Purchase
Hannah M. Hicks, Nikita Pozdeyev, Sharon B. Sams, Umarani Pugazhenthi, Elise S. Bales, Marie-Claude Hofmann, Logan R. McKenna, Rebecca E. Schweppe
Journal: Molecular Cancer Research
Mol Cancer Res (2023) 21 (9): 867–880.
https://doi.org/10.1158/1541-7786.MCR-22-1031
Published: 01 September 2023
View articletitled, Fibronectin Contributes to a BRAF Inhibitor–driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2
Open the PDF for Fibronectin Contributes to a BRAF Inhibitor–driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2 in another window
Includes: Supplementary data
Journal Articles

Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers

Available to Purchase
Rebecca E. Schweppe, Nikita Pozdeyev, Laura A. Pike, Christopher Korch, Qiong Zhou, Sharon B. Sams, Vibha Sharma, Umarani Pugazhenthi, Christopher Raeburn, Maria B. Albuja-Cruz, Philip Reigan, Daniel V. LaBarbera, Iñigo Landa, Jeffrey A. Knauf, James A. Fagin, Bryan R. Haugen
Journal: Molecular Cancer Research
Mol Cancer Res (2019) 17 (5): 1036–1048.
https://doi.org/10.1158/1541-7786.MCR-18-1026
Published: 01 May 2019
View articletitled, Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers
Open the PDF for Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers in another window
Includes: Supplementary data
Journal Articles

FAK Expression, Not Kinase Activity, Is a Key Mediator of Thyroid Tumorigenesis and Protumorigenic Processes

Available to Purchase
Brittelle E. Kessler, Vibha Sharma, Qiong Zhou, Xia Jing, Laura A. Pike, Anna A. Kerege, Sharon B. Sams, Rebecca E. Schweppe
Journal: Molecular Cancer Research
Mol Cancer Res (2016) 14 (9): 869–882.
https://doi.org/10.1158/1541-7786.MCR-16-0007
Published: 13 September 2016
View articletitled, FAK Expression, Not Kinase Activity, Is a Key Mediator of Thyroid Tumorigenesis and Protumorigenic Processes
Open the PDF for FAK Expression, Not Kinase Activity, Is a Key Mediator of Thyroid Tumorigenesis and Protumorigenic Processes in another window
Includes: Supplementary data